Atlas Trials

A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer

Clinical trial NCT00448734 · UNKNOWN

Trial details

NCT number
NCT00448734
Sponsor
Poniard Pharmaceuticals
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hormone Refractory Prostate Cancer
Start date
2006-06-01
Primary completion
2009-12-01
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.